All stock lists
Unlock the score
Kura Oncology, Inc. (NASDAQ:KURA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
9.64+0.03 (+0.31%)
Market cap
$858M
Insider Score
Analyst consensus
Listed since
Sep 16, 2015
Website
Insider Score
/ 100
KURA Insider Score
Kura Oncology, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
KURA analyst forecast
KURA analyst consensus
No analyst ratings in the last 3 months.
KURA 12-month price target
$27.67+187.3% upsideaverage of 3 firms
$40.00High
$15.00Low
Best analysts covering KURA
No firm covering KURA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
KURA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | — | $15.00 | +74.5% | — | 2026-03-13 | |
| Barclays | — | $28.00 | +150.7% | — | 2025-11-24 | |
| H.C. Wainwright | — | $40.00 | +239.6% | — | 2025-11-14 | |
| Stifel Nicolaus | — | $11.00 | +1.9% | — | 2024-11-22 | |
| UBS | — | $27.00 | +58.6% | — | 2024-10-24 | |
| Stifel Nicolaus | — | $19.00 | +2.3% | — | 2024-10-14 | |
| H.C. Wainwright | — | $32.00 | +51.8% | — | 2024-06-25 | |
| Stifel Nicolaus | — | $28.00 | +30.7% | — | 2024-05-23 | |
| Mizuho Securities | — | $26.00 | +88.3% | — | 2023-12-22 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.